20 it-"https:"-"https:"-"https:"-"https:"-"https:" PhD positions at University of Exeter
Sort by
Refine Your Search
-
The GW4 BioMed3 Doctoral Landscape Programme is offering up to 18 MRC funded studentships across a range of biomedical disciplines, with a start date of October 2027. These four-year studentships provide funding for fees and stipend at the rate set by the UKRI, as well as other research training...
-
such risks arise and developing strategies to optimise phage therapy for co-infections, helping unlock its full potential as a next-generation antimicrobial treatment. These studentships are funded through GW4
-
immunomodulatory compound, you will determine how it reprograms host lipid pathways to boost immunity and eliminate infection. Using lipidomics, zebrafish models and clinical samples, this research will identify
-
from animal hosts (are ‘zoonotic’), yet it is hard to predict which pathogen species are likely to cross into human populations and why. This project will combine AI Large Language Models, extracting
-
injury in eating disorders (EDs) by examining neurocognitive mechanisms through fMRI, psychometric assessment, and qualitative interviews. It aims to identify distinct brain activation patterns linked
-
for place with the projects across the MRC GW4 BioMed3 Doctoral Landscape Award studentships. There are a total of 18 studentships available across the partnership. It is well-known that the efficacy
-
disorder with debilitating effects on a patient's quality of life. Because current medications do not work well, we need to study its molecular cause to develop new therapeutics. Recent research identified a
-
to poorer health outcomes. Food insecurity is linked to other eating disorders, but its relationship with ARFID is unknown. This project will explore that gap through large cohort datasets, interviews with
-
to tackle this major clinical challenge. Using advanced data science and 'glucometrics', the standardised analysis of inpatient glucose data, the student will quantify adverse glycaemia, evaluate its impact
-
condition, but its clinical management relies heavily on HbA1c – a biomarker affected by distinct pathways: glucose metabolism (glycaemic) and independent red blood cell biology (non-glycaemic). This means